Search results for "Inde"

showing 10 items of 7365 documents

Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients

2013

Abstract Aims The present study was undertaken to investigate the relationship between glyoxalase 1 (Glo1) enzyme activity and painful diabetic neuropathy (DN) in patients with diabetes mellitus. Methods Glo1 activity and biochemical markers were determined in blood samples from 108 patients with type 1 diabetes, 109 patients with type 2 diabetes, and 132 individuals without diabetes as a control. Painful and painless peripheral DN was assessed and multivariate regression analysis was used to determine independent association of Glo1 activity with occurrence of painful DN. Results In patients with type 1 and type 2 diabetes mellitus and painful DN compared to patients with painless DN, Glo1…

AdultMalemedicine.medical_specialtyMultivariate analysisEndocrinology Diabetes and MetabolismPainType 2 diabetesSeverity of Illness IndexGastroenterologyEndocrinologyDiabetic NeuropathiesInternal medicineDiabetes mellitusInternal MedicinemedicineHumansPain MeasurementGlycated HemoglobinType 1 diabetesbusiness.industryConfoundingLactoylglutathione LyasePeripheral Nervous System DiseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseasePeripheralDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 2Painful diabetic neuropathyDisease ProgressionFemalebusinessBiomarkersJournal of Diabetes and its Complications
researchProduct

Sexual Quality of Life in Patients with Axial Spondyloarthritis in the Biologic Treatment Era.

2019

Author's accepted manuscript. This is a pre-copyediting, author-produced PDF of an article accepted for publication in The Journal of Rheumatology following peer review. The definitive publisher-authenticated version Berg, K. H., Rohde, G., Prøven, A., Benestad, E. E. P., Østensen, M. & Haugeberg, G. (2019). Sexual Quality of Life in Patients with Axial Spondyloarthritis in the Biologic Treatment Era. The Journal of Rheumatology, 46(9), 1075-1083 is available online at: https://www.jrheum.org/content/46/9/1075. Objective. To examine the relationship between demographics, disease-related variables, treatment, and sexual quality of life (SQOL) in men and women with axial spondyloarthritis (ax…

AdultMalemedicine.medical_specialtyMultivariate analysisSexual BehaviorImmunologyDiseasePersonal SatisfactionSeverity of Illness IndexBody Mass Index03 medical and health sciences0302 clinical medicineSex FactorsRheumatologyQuality of lifeInternal medicineSurveys and QuestionnairesSpondylarthritisImmunology and AllergyMedicineOutpatient clinicHumans030212 general & internal medicineAxial spondyloarthritisBASDAI030203 arthritis & rheumatologyBiological Productsbusiness.industryMiddle AgedRheumatologyVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759Antirheumatic AgentsQuality of LifeFemalebusinessBASFIThe Journal of rheumatology
researchProduct

Quality of life, needs, and interest among cocaine users: differences by cocaine use intensity and lifetime severity of addiction to cocaine.

2010

We examined the quality of life (QoL) of 149 patients who were recruited in 2005 at outpatient treatment centers for cocaine dependence in Spain. Important life areas and life areas with potential need and interest to change in order to improve the QoL were analyzed in terms of patients? cocaine use intensity within the previous six months and lifetime severity addiction to cocaine. The Spanish versions of the Drug User Quality of Life Scale and the Lifetime Severity Index for Cocaine were used to measure QoL, needs and interest, and severity addiction to cocaine. The data analysis employed t-tests, linear regression, Mann?Whitney U tests, multivariate regression, and chi-square tests. Tail…

AdultMalemedicine.medical_specialtyMultivariate statisticsHealth (social science)Adolescentmedia_common.quotation_subjectEthnic groupMedicine (miscellaneous)Severity of Illness IndexCocaine dependenceDrug userCocaine-Related DisordersCocaine usersQuality of lifeCocaineOutpatientsmedicineHumansPsychiatrymedia_commonHealth Services Needs and DemandAddictionPublic Health Environmental and Occupational HealthMiddle Agedmedicine.diseaseBehavior AddictivePsychiatry and Mental healthPatient SatisfactionNeeds assessmentLinear ModelsQuality of LifeFemalePsychologyNeeds AssessmentClinical psychologySubstance usemisuse
researchProduct

Parathyroid Hormone as a Novel Biomarker for Chronic Obstructive Pulmonary Disease: Korean National Health and Nutrition Examination Survey

2015

Objective To understand and predict chronic obstructive pulmonary disease (COPD), a biomarker that reflects disease severity is needed. Research Design and Methods Data from 10269 adults aged over 40 years of age were retrieved from the Korea National Health and Nutrition Examination Survey (KNHANES), and 1302 patients met the criteria for COPD. The association between values of vitamin D and parathyroid hormone (PTH), and COPD severity including lung function and quality of life, were analyzed. Results In COPD patients, lung function was inversely related to PTH values (P = 0.02 for FVC [% predicted]; P < 0.001 for FEV1 [% predicted]); however, the association of lung function with vitamin…

AdultMalemedicine.medical_specialtyNational Health and Nutrition Examination Surveylcsh:MedicineParathyroid hormonePulmonary function testingPulmonary Disease Chronic ObstructiveFEV1/FVC ratioInternal medicineRepublic of KoreaVitamin D and neurologyHumansMedicineVitamin Dlcsh:ScienceLungAgedCOPDMultidisciplinarybusiness.industrylcsh:RMiddle AgedNutrition Surveysmedicine.diseaseRespiratory Function Testsrespiratory tract diseasesEndocrinologyParathyroid HormoneMultivariate AnalysisQuality of LifeBiomarker (medicine)lcsh:QFemalebusinessBody mass indexBiomarkersResearch ArticlePLOS ONE
researchProduct

Mirtazapine compared with paroxetine in major depression.

2000

Background: The aim was to compare the efficacy and tolerability of mirtazapine with those of paroxetine. Method: 275 outpatients with a diagnosis of major depressive episode (DSM-IV) and a score ≥ 18 on the 17-item Hamilton Rating Scale for Depression (HAM-D-17) were randomly assigned to 6 weeks of treatment with mirtazapine (15-45 mg/day) or paroxetine (20-40 mg/day). Efficacy was assessed by the HAM-D-17, Hamilton Rating Scale for Anxiety (HAM-A), and Clinical Global Impressions scales (Severity and Improvement), and analyses were performed on the intent-to-treat sample (127 mirtazapine-treated patients and 123 paroxetine-treated patients). Results: Mean daily doses were 32.7 mg of mirta…

AdultMalemedicine.medical_specialtyNauseaMirtazapineMirtazapineMianserinAntidepressive Agents TricyclicSeverity of Illness IndexDrug Administration Schedulelaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineAmbulatory CareHumansPsychiatryMajor depressive episodeAgedPsychiatric Status Rating ScalesDepressive DisorderHamilton Rating Scale for DepressionMiddle AgedParoxetinePsychiatry and Mental healthParoxetineTreatment OutcomeTolerabilityAnxietyFemalemedicine.symptomPsychologymedicine.drugThe Journal of clinical psychiatry
researchProduct

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

2010

On the basis of promising results that were reported in several phase 2 trials, we investigated whether the addition of the monoclonal antibody rituximab to first-line chemotherapy with fludarabine and cyclophosphamide would improve the outcome of patients with chronic lymphocytic leukaemia.Treatment-naive, physically fit patients (aged 30-81 years) with CD20-positive chronic lymphocytic leukaemia were randomly assigned in a one-to-one ratio to receive six courses of intravenous fludarabine (25 mg/m(2) per day) and cyclophosphamide (250 mg/m(2) per day) for the first 3 days of each 28-day treatment course with or without rituximab (375 mg/m(2) on day 0 of first course, and 500 mg/m(2) on da…

AdultMalemedicine.medical_specialtyNeutropeniaFCR RegimenKaplan-Meier EstimateOfatumumabSeverity of Illness IndexGastroenterologyDisease-Free SurvivalDrug Administration ScheduleAntibodies Monoclonal Murine-Derivedchemistry.chemical_compoundChemoimmunotherapyObinutuzumabInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansImmunologic FactorsMedicineCyclophosphamideAgedAged 80 and overbusiness.industryIncidenceAntibodies MonoclonalLeukopeniaGeneral MedicineMiddle AgedLeukemia Lymphocytic Chronic B-CellSurgeryFludarabineTreatment OutcomechemistryDisease ProgressionFemaleRituximabRefractory Chronic Lymphocytic LeukemiaRituximabbusinessVidarabineUntreated Chronic Lymphocytic Leukemiamedicine.drug
researchProduct

Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropenia.

2002

Sepsis in chemotherapy-associated neutropenia is a major cause of mortality in the treatment of acute myeloid leukemia (AML). Early diagnosis of sepsis is crucial for patient survival. We analyzed the value of prospectively measuring serum concentrations of soluble tumor necrosis factor receptor type II (sTNF-RII) in patients with AML for early diagnosis of sepsis in neutropenia. Therefore, 54 adult patients with AML and neutropenia were followed around the onset of fever. A total of 59 febrile episodes were documented. We could not demonstrate a significant increase in sTNF-RII levels prior to fever. sTNF-RII concentrations were not predictive of the severity of a febrile episode. Based on…

AdultMalemedicine.medical_specialtyNeutropeniaTime FactorsFevermedicine.medical_treatmentPilot ProjectsNeutropeniaInfectionsGastroenterologySeverity of Illness IndexReceptors Tumor Necrosis FactorSepsisAntigens CDhemic and lymphatic diseasesInternal medicinemedicineHumansReceptors Tumor Necrosis Factor Type IIProspective StudiesAgedChemotherapyHematologyLeukopeniabusiness.industryOsmolar ConcentrationMyeloid leukemiaHematologyGeneral MedicineMiddle Agedmedicine.diseaseSolubilityLeukemia MyeloidImmunologyAcute DiseaseTumor necrosis factor alphaFemalemedicine.symptombusinessComplicationAnnals of hematology
researchProduct

Multidimensional assessment of OCD: integration and revision of the Vancouver Obsessional-Compulsive Inventory and the Symmetry Ordering and Arrangin…

2010

This article reports on the integration and revision of two self-report measures of obsessive-compulsive symptoms based on data from an obsessive-compulsive disorder (OCD) sample (n=228): the Vancouver Obsessional-Compulsive Inventory (VOCI) and the Symmetry Ordering and Arranging Questionnaire (SOAQ). The revised measure provides scores on five symptom subscales (Contamination, Checking, Hoarding, Symmetry and Ordering, Obsessions). It shows improvement upon current versions in several ways: it has a good model fit, eliminates redundancy, reduces overlap across subscales, is much shorter, and covers those OCD dimensions most frequently identified in factor-analytic studies. Strengths of th…

AdultMalemedicine.medical_specialtyObsessive-Compulsive DisorderPsychometricsTest validityAmbulatory Care FacilitiesPersonality DisordersSeverity of Illness IndexArts and Humanities (miscellaneous)Surveys and QuestionnairesmedicineHumansPsychiatryReferral and ConsultationDepressive DisorderDiscriminant validityConstruct validitymedicine.diseaseAnxiety DisordersPsychophysiologic DisordersClinical PsychologyConvergent validityAnxietyOptimal distinctiveness theoryFemalemedicine.symptomPsychologyAnxiety disorderClinical psychologyJournal of clinical psychology
researchProduct

Meibomian glands structure in daily disposable soft contact lens wearers: a one‐year follow‐up study

2020

Purpose To assess the impact of daily disposable soft contact lenses on meibomian gland morphology over a period of 12 months. Methods Forty-one subjects (33 experienced and 8 neophytes) were fitted with either silicone-hydrogel or hydrogel daily contact lenses. The study protocol included four visits: baseline, day-2 for contact lens fit and follow-up measurements, as well as after 6 and 12 months of lens wear. Non-contact infrared meibography images were acquired with Keratograph 5M topographer (www.oculus.de) and analysed with an automated method, which objectively estimates the area of gland atrophy, gland length and width, number of glands and gland irregularity. Protocol at follow-up …

AdultMalemedicine.medical_specialtyOne year follow upMeibomian glandlaw.inventionYoung Adult03 medical and health sciences0302 clinical medicineAtrophylawOphthalmologyHumansMedicineOcular Surface Disease IndexProspective StudiesVision Ocularbusiness.industryOsmolar ConcentrationMeibomian GlandsContact Lenses Hydrophilicmedicine.diseaseeye diseasesSensory SystemsLens (optics)Contact lensOphthalmologymedicine.anatomical_structurePatient SatisfactionTears030221 ophthalmology & optometryFemaleDaily disposablesense organsbusinessEarly phase030217 neurology & neurosurgeryFollow-Up StudiesOptometryOphthalmic and Physiological Optics
researchProduct

Risk for periodontal disease in patients with longstanding rheumatoid arthritis.

1998

Objective. To quantify periodontal disease in rheumatoid arthritis (RA) patients and controls, and to correlate the degree of destruction from periodontal disease and from RA Methods. Fifty RA patients were matched for age, sex, smoking status, and oral hygiene with 101 controls. Correlations between indices of chronic destruction in periodontal disease (gingival attachment loss) and in RA (Larsen radiographic score) were determined. Results. Patients with longstanding active RA (mean ± SD 13 ± 8 years) who were receiving treatment with disease-modifying antirheumatic drugs (n = 46), corticosteroids (n = 38), or nonsteroidal antiinflammatory drugs (n = 43) had a higher rate of gingival blee…

AdultMalemedicine.medical_specialtyOral Hygiene IndexImmunologyGingivaArthritisDentistryOral hygieneGastroenterologyArthritis RheumatoidRheumatologyRisk FactorsInternal medicineImmunopathologyOral and maxillofacial pathologymedicineImmunology and AllergyHumansPharmacology (medical)Risk factorArthrographyAgedAutoimmune diseasebusiness.industryMiddle Agedmedicine.diseaseOral HygieneClinical attachment lossRheumatoid arthritisGingival DiseasesDisease ProgressionFemaleJointsbusinessArthritis and rheumatism
researchProduct